Effect of metabolic inhibitors and chelating agents on 59Fe uptake by the placental tissues of the rat, Rattus norvegicus.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D000968:Antimycin A / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology*; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D066298:In Vitro Techniques; D007501:Iron / Q000378:metabolism*; D007504:Iron Radioisotopes; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D010920:Placenta / Q000187:drug effects / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D011247:Pregnancy; D011817:Rabbits / Q000276:immunology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D014168:Transferrin / Q000378:metabolism; D014817:Vitelline Membrane / Q000187:drug effects / Q000378:metabolism*
D000081:Acetamides; D000963:Antimetabolites; D001386:Azides; D002614:Chelating Agents; D003486:Cyanides; D004140:Dinitrophenols; D007504:Iron Radioisotopes; D014168:Transferrin; D000968:Antimycin A; D012964:Sodium; D007501:Iron; D005459:Fluorides; D011188:Potassium